CRBP 2.50 Average entry $5 Analyst high target $40 77% drop on Tuesday as results of the Phase 3 trial were not much better than placebo group. This was unexpected by those running the trials and management. It is thought that perhaps the Immunosuppressive drugs that 84% of...
INMB at 9.40 1 day after report, high of 10.60 on 8/20 post report and now 9.20 low today I have a few more items to help understand what they are doing with their TNF Inhibitor science which targets Inflammation and Cytokine storm issues that cause...
INMB- Inmune Bio $9.65 area Investing Advice: Buy from 9.50-10.50 ranges to accumulate a position Target is $25 plus in 6-12 months (Back to recent highs) Trading below the recent $10 secondar y offering and a gap fill area completed, this is the Tipping Point to buy the stock...
TFFP announced their quarterly update yesterday and the stock rallied as high as $14 post close from $10.28 52 week highs afterwards. They announced a worldwide licensing agreement for Niclosamide with Union Therapeutics. This is transformational and has 210 million in milestone payments, royalties, and...
Quick notes PRVB is back over 12 now after hitting 10.20 area last week. I posted on Stocktwits then I felt we hit a long term bottom and would march to 18 plus into the BLA application for Teplizumab. This is a good time to buy...
VIR- Closing out here at 46 area for 55% final gains on final 1/2 OTRK- Closing out final half here for 140% gains on final 1/2...
TBIO $16.30 area down from $28.09 highs in June on Sanofi news Tipping point to buy the stock after material drop following great news. Looks purely technical related and comes with insider buying.- Dave 67 Million shares outstanding, 1.1 billion market cap, 700 million cash. Translate Bio is...
The TPS Portfolio overall is doing great Unable to do charts today as Amazon AWS is having issues and I cant load Stockcharts.com now Action Items: Closing SOLY for loss, Holding SAMAW even though down big on paper Likely issuing new research buy report possibly this week or...
VIR 49.60 We are selling half here as we met my initial $45 plus target and at 49.50 we are up over 60% Holding half...
OTRK- (Formerly CATS or Catasys) $29.20 area Average Entry $15.50-$16 in 2019, Up 82% plus This has had a great rally after hitting 32, back to 17, now 29-30 on recovery. Still like this long term, but like with PRVB where we sold 1/2 at 16.25 alert now...
indian xxnx horny desi indian cheating slime wife show boobs in webcam.
